Markets:

Overview

News

Currencies

International

Treasuries

Absci Corporation - Common Stock (NQ:ABSI)

3.178 +0.118 (+3.85%)

Streaming Delayed Price Updated: 10:30 AM EDT, Apr 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Absci Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease

May 13, 2025

From Absci Corporation

Via GlobeNewswire

Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025

April 14, 2025

From Absci Corporation

Via GlobeNewswire

Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing ↗

April 14, 2025

FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective and human relevant methods.

Via Benzinga

Topics Animal Testing

Peering Into Absci's Recent Short Interest ↗

January 31, 2025

Via Benzinga

Earnings Scheduled For May 13, 2025 ↗

May 13, 2025

Via Benzinga

Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday ↗

April 11, 2025

Via Benzinga

Health Care Technology Stocks Surge After FDA Announces Plans To Phase Out Animal Testing Requirements ↗

April 10, 2025

Several stocks in the health care technology space are moving higher after the market close on Thursday after the U.S. Food and Drug Administration (FDA) announced plans to phase out animal testing...

Via Benzinga

Topics Animal Testing

Absci Stock: A Deep Dive Into Analyst Perspectives (7 Ratings) ↗

April 09, 2025

Via Benzinga

Which Healthcare Stock Is the Best Buy Right Now?

March 31, 2025

Healthcare stocks provide a combination of upstarts with a high risk, high reward proposition to established firms that can be a defensive maneuver.

Via MarketBeat

Absci to Participate in Upcoming Investor Conferences

March 26, 2025

From Absci Corporation

Via GlobeNewswire

Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen ↗

March 22, 2025

Cathie Wood-led Ark Invest made notable trades, buying IRDM, BEAM, PACB, ABSI and selling ILMN, RPTX, AMGN, VEEV.

Via Benzinga

Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

March 19, 2025

Via Benzinga

A Glimpse Into The Expert Outlook On Absci Through 7 Analysts ↗

March 19, 2025

Via Benzinga

Why StoneCo Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket ↗

March 19, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

March 18, 2025

Via Benzinga

Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results

March 18, 2025

From Absci Corporation

Via GlobeNewswire

Earnings Scheduled For March 18, 2025 ↗

March 18, 2025

Via Benzinga

Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dip ↗

March 08, 2025

Ark Invest made significant trades on Friday, selling shares of RBLX, ROKU, PATH and buying shares of IBTA, PSNL, ABSI, and RXRX.

Via Benzinga

Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025

March 04, 2025

From Absci Corporation

Via GlobeNewswire

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

March 04, 2025

From Absci Corporation

Via GlobeNewswire

Absci to Participate in the KeyBanc Capital Markets Healthcare Forum

March 04, 2025

From Absci Corporation

Via GlobeNewswire

Absci to Participate in the TD Cowen 45th Annual Health Care Conference

February 18, 2025

From Absci Corporation

Via GlobeNewswire

What's going on in today's after hours session ↗

February 17, 2025

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Via Chartmill

Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales ↗

January 22, 2025

Via Benzinga

Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside ↗

January 22, 2025

Needham initiated a Buy rating for Absci (ABSI), noting its AI-powered drug discovery platforms, strategic partnerships, and $9 price target.

Via Benzinga

Nasdaq Surges 1.5%; Procter & Gamble Posts Upbeat Earnings ↗

January 22, 2025

Via Benzinga

Seagate Posts Upbeat Earnings, Joins Netflix, Travelers, Teledyne Technologies And Other Big Stocks Moving Higher On Wednesday ↗

January 22, 2025

Via Benzinga

Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference

January 22, 2025

From Absci Corporation

Via GlobeNewswire

This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

January 22, 2025

Via Benzinga

Cathie Wood's Ark Invest Buys Into Defense And Energy Stocks Amid Trump's Inaugural Policies ↗

January 22, 2025

Cathie Wood-led Ark Invest made significant trades involving ACCD, DE, NTLA, PATH, CCJ, OKLO, ILMN, ESLT, and ABSI.

Via Benzinga

Topics Government

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.